LV Diastolic Dysfunction Among the Patients With Systolic Heart Failure-clinical Significance and Prognostic Importance.

Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure

NCT03446651 ·Status: COMPLETED ·Phase: EARLY_PHASE1

The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

NCT04217135 ·Status: UNKNOWN ·Phase: PHASE4

Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients

NCT01930734 ·Status: UNKNOWN ·Phase: PHASE4

Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

NCT04397302 ·Status: COMPLETED

The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era

NCT05973591 ·Status: UNKNOWN

Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations

NCT03764722 ·Status: UNKNOWN ·Phase: PHASE4

Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy

NCT04575675 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure

NCT00323037 ·Status: COMPLETED ·Phase: PHASE3

Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy

NCT00354328 ·Status: COMPLETED

Peroral Levosimendan in Chronic Heart Failure

NCT00130884 ·Status: COMPLETED ·Phase: PHASE2

Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study

NCT02441218 ·Status: COMPLETED ·Phase: PHASE3

Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction

NCT05849766 ·Status: COMPLETED ·Phase: PHASE3

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

NCT05795400 ·Status: COMPLETED ·Phase: NA

Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy

NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2

Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.

NCT02408003 ·Status: COMPLETED ·Phase: NA

Semaphorins 3A and 4D Levels in Heart Failure Patients

NCT02406716 ·Status: UNKNOWN

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2

Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes

NCT03631654 ·Status: WITHDRAWN ·Phase: PHASE4

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

NCT06979375 ·Status: RECRUITING ·Phase: PHASE2

Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF

NCT04757584 ·Status: COMPLETED ·Phase: PHASE4

A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels

NCT00271557 ·Status: COMPLETED ·Phase: PHASE3

Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

NCT00338455 ·Status: TERMINATED ·Phase: PHASE2

Effect of Dapagliflozin on VT in Patients With Heart Failure.

NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4

Levosimendan In Ambulatory Heart Failure Patients

NCT04705337 ·Status: TERMINATED ·Phase: PHASE4

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

NCT06979362 ·Status: RECRUITING ·Phase: PHASE2